Literature DB >> 2079718

Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET).

S L Dewey1, N D Volkow, J Logan, R R MacGregor, J S Fowler, D J Schlyer, B Bendriem.   

Abstract

Muscarinic cholinergic M1 and M2 receptors in young and aged adult male volunteers were studied using [N-11C-methyl]-benztropine, a specific muscarinic cholinergic receptor ligand, and high resolution positron emission tomography (PET). A regionally specific pattern of decreased binding was observed in aged volunteers. Using two separate methods of data analysis, thalamic, hippocampal and cerebellar regions showed no decreases in the apparent specific binding of [N-11C-methyl]-benztropine while frontal, parietal, temporal and occipital cortices as well as the corpus striatum showed age related changes in binding that declined (in 82 yrs old subject) to about 50% of the value obtained from the youngest volunteer (19 yrs). These data suggest that regions high in muscarinic receptor density, the corpus striatum and the cortical mantle, show a greater rate of decline than those areas that have a relatively low number of muscarinic receptors. Furthermore, this study demonstrates the usefulness of PET and [N-11C-methyl]-benztropine for assessing age related regional changes in muscarinic cholinergic receptor binding in the living human brain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079718     DOI: 10.1002/jnr.490270418

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

Review 1.  The postictal state: effects of age and underlying brain dysfunction.

Authors:  William H Theodore
Journal:  Epilepsy Behav       Date:  2010-08-17       Impact factor: 2.937

2.  Age-dependent MRI-detected lesions at early stages of transient global ischemia in rat brain.

Authors:  R Canese; P Lorenzini; S Fortuna; M T Volpe; M Giannini; F Podo; H Michalek
Journal:  MAGMA       Date:  2004-12-21       Impact factor: 2.310

3.  Central Anticholinergic Adverse Effects and Their Measurement.

Authors:  Pasi Lampela; Teemu Paajanen; Sirpa Hartikainen; Risto Huupponen
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

4.  Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptors as evaluated by positron emission tomography in the Rhesus monkey.

Authors:  Y Tani; T Ishihara; T Kanai; T Ohno; J Andersson; A Lilja; G Antoni; K J Fasth; P Bjurling; G Westerberg
Journal:  J Neural Transm Gen Sect       Date:  1995

5.  Functional activation of Gαq coupled to 5-HT2A receptor and M1 muscarinic acetylcholine receptor in postmortem human cortical membranes.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Toshio Ota; J Javier Meana; Luis F Callado; Jesús A García-Sevilla
Journal:  J Neural Transm (Vienna)       Date:  2017-07-07       Impact factor: 3.575

6.  Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use.

Authors:  Robert D Nebes; Bruce G Pollock; Edythe M Halligan; Patricia Houck; Judith A Saxton
Journal:  Am J Geriatr Psychiatry       Date:  2011-02       Impact factor: 4.105

7.  Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.

Authors:  M Asahina; T Suhara; H Shinotoh; O Inoue; K Suzuki; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

8.  Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study.

Authors:  Pasi Lampela; Piia Lavikainen; J Arturo Garcia-Horsman; J Simon Bell; Risto Huupponen; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2013-05       Impact factor: 3.923

9.  Functional and neurobiological similarities of aging in monkeys and humans.

Authors:  M L Voytko
Journal:  Age (Omaha)       Date:  1997-01

10.  Compensatory responses to age-related decline in odor quality acuity: cholinergic neuromodulation and olfactory enrichment.

Authors:  Nathalie Mandairon; Shane T Peace; Karim Boudadi; Christine E Boxhorn; Venkata Anupama Narla; Sara D Suffis; Thomas A Cleland
Journal:  Neurobiol Aging       Date:  2010-01-15       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.